<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Ritter, Philippe</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Micra Transcatheter Pacing System Safe, Effective</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-08-07 11:12:17</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">8-9</style></pages><abstract><style  face="normal" font="default" size="100%">According to early performance results from a single-arm trial, the Micra Transcatheter Pacing System was safe and effective in patients who required ventricular pacing for a variety of conditions. The serious adverse event rate was 5.7%, but there were no device-related deaths, infections, dislodgements, or reoperation.</style></abstract><number><style face="normal" font="default" size="100%">22</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>